Cargando…

Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells

The chromosome 11q13 region is frequently amplified in human carcinomas and results in an increased expression of various genes including cortactin, and is also associated with an increased invasive potential. Cortactin acts as an important regulator of the actin cytoskeleton. It is therefore very t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rossum, Agnes GSH, Gibcus, Johan, van der Wal, Jacqueline, Schuuring, Ed
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410772/ https://www.ncbi.nlm.nih.gov/pubmed/16280034 http://dx.doi.org/10.1186/bcr1316

Ejemplares similares

Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice
por: van Rossum, Agnes GSH, et al.
Publicado: (2006)

Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain
por: van Rossum, Agnes GSH, et al.
Publicado: (2005)

Cortactin expression predicts poor survival in laryngeal carcinoma
por: Gibcus, J H, et al.
Publicado: (2008)

Cortactin enhances exosome secretion without altering cargo
por: Gangoda, Lahiru, et al.
Publicado: (2016)

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status
por: Hofman, P, et al.
Publicado: (2008)

Cortactin Is a Substrate of Activated Cdc42-Associated Kinase 1 (ACK1) during Ligand-induced Epidermal Growth Factor Receptor Downregulation
por: Kelley, Laura C., et al.
Publicado: (2012)

Releasing the brakes while hanging on: Cortactin effects on actin-driven motility
por: Gov, Nir S., et al.
Publicado: (2012)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Association of Cortactin, Fascin-1 and Epidermal Growth Factor Receptor (EGFR) Expression in Ovarian Carcinomas: Correlation with Clinicopathological Parameters
por: Lin, Chih-kung, et al.
Publicado: (2008)

The Function of Cortactin in the Clustering of Acetylcholine Receptors at the Vertebrate Neuromuscular Junction
por: Madhavan, Raghavan, et al.
Publicado: (2009)

Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer
por: Yun, Sumi, et al.
Publicado: (2018)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

Correction: The Function of Cortactin in the Clustering of Acetylcholine Receptors at the Vertebrate Neuromuscular Junction
por: Madhavan, Raghavan, et al.
Publicado: (2010)

Cortactin regulates the activity of small GTPases and ICAM-1 clustering in endothelium: Implications for the formation of docking structures
por: Vestweber, Dietmar, et al.
Publicado: (2013)

Activation of signaling receptors: do ligands bind to receptor monomer, dimer, or both?
por: Pang, Xiaodong, et al.
Publicado: (2013)

Radiosensitization of head and neck cancer by targeting the epidermal growth factor receptor
por: Goel, Arun Kumar, et al.
Publicado: (2009)

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization
por: Gee, Julia MW, et al.
Publicado: (2003)

Novel role of cortactin in G protein-coupled receptor agonist-induced nuclear export and degradation of p21Cip1
por: Janjanam, Jagadeesh, et al.
Publicado: (2016)

Cortactin and dynamin are required for the clathrin-independent endocytosis of γc cytokine receptor
por: Sauvonnet, Nathalie, et al.
Publicado: (2005)

Rhomboids and regulation of receptor tyrosine kinase ligands shedding
por: Karachaliou, Niki, et al.
Publicado: (2018)

Cortactin function in invadopodia
por: Jeannot, Pauline, et al.
Publicado: (2017)

Wnt signalling via the epidermal growth factor receptor: a role in breast cancer?
por: Musgrove, Elizabeth A
Publicado: (2004)

Quantification of Receptor Occupancy by Ligand—An Understudied Class of Potential Biomarkers
por: Veeramani, Suresh, et al.
Publicado: (2020)

pTyr(421) Cortactin Is Overexpressed in Colon Cancer and Is Dephosphorylated by Curcumin: Involvement of Non-Receptor Type 1 Protein Tyrosine Phosphatase (PTPN1)
por: Radhakrishnan, Vijayababu M., et al.
Publicado: (2014)

Internalization Mechanisms of the Epidermal Growth Factor Receptor after Activation with Different Ligands
por: Henriksen, Lasse, et al.
Publicado: (2013)

“The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology”: letter to the Editor
por: Dinjens, Winand N. M., et al.
Publicado: (2020)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease
por: Makki, Nader, et al.
Publicado: (2013)

Polarized Endocytosis of the Keratinocyte Growth Factor Receptor in Migrating Cells: Role of Src-Signaling and Cortactin
por: Belleudi, Francesca, et al.
Publicado: (2011)

Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)
por: Zhao, Yin, et al.
Publicado: (2020)

p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
por: Yoon, K. S., et al.
Publicado: (2001)

Commentary: Guideline for Performing Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Quantitative Image Analysis well
por: Beckwith, Bruce
Publicado: (2019)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

Epidermal Overexpression of Xenobiotic Receptor PXR Impairs the Epidermal Barrier and Triggers Th2 Immune Response
por: Elentner, Andreas, et al.
Publicado: (2017)

To bind or not to bind – how to down-regulate target genes by liganded thyroid hormone receptor?
por: Weitzel, Joachim M
Publicado: (2008)

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
por: Avila, Jorge, et al.
Publicado: (2023)

Epidermal growth factor receptor (EGFR) biology and Wnt developmental signaling highlight research endeavors of SCBA award winners
por: Jeang, Kuan-Teh
Publicado: (2012)

The Kinetics of the Hydrogen/Deuterium Exchange of Epidermal Growth Factor Receptor Ligands
por: Iloro, Ibon, et al.
Publicado: (2008)

Ligand binding and dynamics of the monomeric epidermal growth factor receptor ectodomain
por: Loeffler, Hannes H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s7c14dsps4188ihmifh71ckbmc